Zydus LifeSciences enters into BTA for purchase from Watson Pharma
The Business Undertaking was catering to the API requirements of Teva group and there was no external sale to third parties<br />
Industrial talks | 30/11/2022 | By Sudeep Soparkar | 1099
Symbio Generrics completes capital raise from Ascent Capital
The funds raised from Ascent will be utilised towards undertaking strategic acquisitions, establishing a best-in-class R&D facility and ramping up manufacturing capacity
<br />
Industrial talks | 25/11/2022 | By Sudeep Soparkar | 989
Stephen Hermitage joins Sai Life Sciences as VP, CMC
He will add further deep scientific, process development and drug development experience to the R&D organisation
<br />
Industrial talks | 23/11/2022 | By Sudeep Soparkar | 384
Aurobindo Pharma's arm Eugia Pharma Specialities bags
This is a partnership product from TTY Biopharm Company and will be manufactured at the Taiwan facility
Industrial talks | 18/11/2022 | By Sudeep Soparkar | 1222
Pfeiffer Vacuum introduces SmartVane rotary vane pump for mass spectrometry
The vacuum pump is designed to ensure that no oil leaks occur therefore preventing any contamination
Industrial talks | 16/11/2022 | By Sudeep Soparkar | 652
Ingersoll Rand reaffirms commitment, investments in India
Optimistic that local manufacturing will also help ensure faster delivery and deployment time alongside better cost benefits across the pharma sector
Industrial talks | 14/11/2022 | By Sudeep Soparkar | 747
JB Pharma commits to ESG in its maiden Sustainability Report
The sustainability report is for the year FY 2021 – 2022
Industrial talks | 17/10/2022 | By Sudeep Soparkar | 595
Cipla's OSD plant bags Global Lighthouse Network recognition
Cipla deployed 'Digital Automation Analytics' (DAA) across a network of 22 India sites in parallel to unlock end-to-end costs, productivity and quality leadership
Industrial talks | 12/10/2022 | By Sudeep Soparkar | 1767
Lupin appoints Shahin Fesharaki as Global Chief Scientific Officer
Fesharaki will be in charge of Lupin's global R&D operations spanning branded, generic, and speciality products
Industrial talks | 07/10/2022 | By Sudeep Soparkar | 860
Supriya Lifescience appoints Rajeev Kumar Jain as CEO
He has over 35+ years of rich functional experience in the manufacturing domain of bulk drugs, intermediate and API
Industrial talks | 03/10/2022 | By Sudeep Soparkar | 1150
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy